ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2 | -100.0% | 1,500 | -94.9% | 0.00% | -100.0% |
| Q4 2021 | $146,000 | +1522.2% | 29,200 | +3550.0% | 0.01% | – |
| Q3 2021 | $9,000 | -43.8% | 800 | -77.8% | 0.00% | -100.0% |
| Q2 2021 | $16,000 | -27.3% | 3,600 | +350.0% | 0.00% | 0.0% |
| Q1 2021 | $22,000 | -4.3% | 800 | -20.0% | 0.00% | 0.0% |
| Q4 2020 | $23,000 | -30.3% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $33,000 | -21.4% | 1,000 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $42,000 | -35.4% | 1,000 | -81.8% | 0.00% | 0.0% |
| Q1 2020 | $65,000 | -72.6% | 5,500 | -16.7% | 0.00% | -78.6% |
| Q4 2019 | $237,000 | +139.4% | 6,600 | +112.9% | 0.01% | +55.6% |
| Q3 2019 | $99,000 | +20.7% | 3,100 | +24.0% | 0.01% | +12.5% |
| Q2 2019 | $82,000 | -31.7% | 2,500 | -30.6% | 0.01% | -33.3% |
| Q1 2019 | $120,000 | -37.5% | 3,600 | -71.4% | 0.01% | -33.3% |
| Q4 2018 | $192,000 | -24.7% | 12,600 | -19.7% | 0.02% | 0.0% |
| Q3 2018 | $255,000 | +363.6% | 15,700 | -0.6% | 0.02% | +350.0% |
| Q2 2018 | $55,000 | -83.4% | 15,800 | -15.1% | 0.00% | -85.7% |
| Q1 2018 | $331,000 | +55.4% | 18,600 | -35.4% | 0.03% | +211.1% |
| Q4 2017 | $213,000 | +53.2% | 28,800 | +89.9% | 0.01% | +80.0% |
| Q3 2017 | $139,000 | -84.1% | 15,166 | -84.2% | 0.01% | -84.4% |
| Q2 2017 | $875,000 | +50.3% | 95,949 | -30.1% | 0.03% | +28.0% |
| Q1 2017 | $582,000 | +94.0% | 137,245 | +300.5% | 0.02% | +127.3% |
| Q4 2016 | $300,000 | +91.1% | 34,266 | +69.2% | 0.01% | +57.1% |
| Q3 2016 | $157,000 | +57.0% | 20,255 | +88.3% | 0.01% | +40.0% |
| Q2 2016 | $100,000 | -47.1% | 10,755 | -75.0% | 0.01% | -58.3% |
| Q1 2016 | $189,000 | +37.0% | 43,046 | +193.3% | 0.01% | +71.4% |
| Q4 2015 | $138,000 | – | 14,678 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |